Swine Vaccines Industry Overview
The global swine vaccines market size was valued at USD 1.5 billion in 2021 and is expected to expand at a CAGR of 4.9% from 2022 to 2030.
Some of the key factors attributing to the growth of the market include the growing food security concerns with rising swine disease outbreaks and zoonoses coupled with the wide adoption of antibiotic-free disease preventive approaches. Some highly contagious swine diseases such as porcine reproductive and respiratory syndrome (PRRS) and swine influenza remain to be highly prevalent among swine herds of Asian, Europe, and American regions contributing to severe economic loss. Therefore, to curb the effect swine producers are widely implementing biosecurity measures and vaccination processes.
Gather more insights about the market drivers, restrains and growth of the Global Swine Vaccines Market
Due to the increasing number of swine disease outbreaks reported in major swine-raising countries, the customer demand for innovative, fast, safe, and effective vaccines is growing. For instance, according to the OIE, between 2016 to 2020, the Asian swine herds reported 9,928 outbreaks of African swine fever, followed by 4,721 outbreaks in Europe. Government organizations and pharmaceutical industries are continuously launching novel vaccines to combat this severe swine health concern. For instance, on June 2022, Vietnam announced that it had successfully developed the ASF vaccine which was aimed to be circulated throughout the country’s swine farms. However, the vaccine was temporarily suspended for use on August 2022, due to the vaccinated death rates.
The COVID-19 pandemic hampered the distribution of highly required swine vaccines during the initial months of the year 2020, which caused severe loss to swine producers, and swine vaccine manufacturers. This was due to the lockdowns and supply chain restrictions implemented across the world to curb the spread of covid-19 infection. The governments and healthcare sectors were focusing on handling the human emergency treatments during the crisis and simultaneously challenged to manage the rising incidence of contagious swine diseases that has been affecting the overall livestock industry. Significant measures such as import and export bans, strengthened biosecurity measures, routine surveillance & epidemiological investigations, and necessary vaccinations have been intimated to curb the spread in various regions.
Moreover, companies in the market are launching various innovative vaccine technologies and solutions, which is also enhancing market growth. For instance, in October 2019, Boehringer Ingelheim gained authorization from EMA for ReprocycParvoFLEX, the first subunit porcine parvovirus vaccine to protect swine fetuses against transplacental infection. In addition, veterinary universities are focused on delivering vaccination services to help small-scale swine farmers with disease control measures. For instance, the College of Veterinary Medicine, the University of Illinois, created a website to provide information and resources to pork producers for their biosecurity program on farms. Training farm employees and developing a biosecurity plan are essential measures for preventing high-risk pathogens from entering and affecting swine farms. These factors are further improving the growth of the market.
Browse through Grand View Research's Animal Health Industry Research Reports
- Veterinary Biomarkers Market: The global veterinary biomarkers market size was estimated at USD 716.9 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 12.5% from 2022 to 2030.
- Animal Biotechnology Market: The global animal biotechnology market size was valued at USD 22.66 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.2% from 2022 to 2030.
Swine Vaccines Market Segmentation
Grand View Research has segmented the global swine vaccines market based on product, type, and region:
Swine Vaccines Product Outlook (Revenue, USD Million, 2017 - 2030)
- Attenuated Live Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- DNA Vaccines
- Recombinant Vaccines
Swine Vaccines Type Outlook (Revenue, USD Million, 2017 - 2030)
- Swine Influenza
- Classical Swine Fever
- Porcine Parvovirus
- Porcine Circovirus Type 2
- Actinobacillus Pleuropneumonia
- Foot & Mouth Disease
Swine Vaccines Regional Outlook (Revenue, USD Million, 2016 - 2028)
- North America
- Asia Pacific
- Latin America
- Middle East and Africa (MEA)
Market Share Insights
- February 2021: Algenex SL and Virbac proclaimed that they have entered an international licensing agreement for the development and commercialization of a CrisBio-based vaccine in a key swine indication.
- June 2020: Boehringer Ingelheim received a New Veterinary Drug Registration Certificate from the Ministry of Agriculture and Rural Affairs of China for Ingelvac CSF MLV. This is the first CSF live vaccine developed jointly by Chinese research institutes and multinational companies.
- February 2020: ICAR-Indian Veterinary Research Institute has introduced a new locally created vaccine for managing CSF, which costs only Rs. 2 per dose.
Key Companies profiled:
Some of the prominent players in the global swine vaccines market include:
- Merck & Co., Inc.
- Boehringer Ingelheim GmbH
- Indian Immunologicals Ltd.
- Phibro Animal Health
- KM Biologics
Order a free sample PDF of the Swine Vaccines Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Corporate Sales Specialist, USA
Grand View Research, Inc.
Toll Free: 1-888-202-9519